Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools.

Chmielewski JP, Bowlby SC, Wheeler FB, Shi L, Sui G, Davis AL, Howard TD, D'Agostino RB Jr, Miller LD, Sirintrapun SJ, Cramer SD, Kridel SJ.

Mol Cancer Res. 2018 Nov;16(11):1687-1700. doi: 10.1158/1541-7786.MCR-17-0526. Epub 2018 Aug 3.

PMID:
30076241
2.

Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations.

Senkevitch E, Li W, Hixon JA, Andrews C, Cramer SD, Pauly GT, Back T, Czarra K, Durum SK.

Oncotarget. 2018 Apr 27;9(32):22605-22617. doi: 10.18632/oncotarget.25194. eCollection 2018 Apr 27.

3.

Plasticity in early immune evasion strategies of a bacterial pathogen.

Bernard Q, Smith AA, Yang X, Koci J, Foor SD, Cramer SD, Zhuang X, Dwyer JE, Lin YP, Mongodin EF, Marques A, Leong JM, Anguita J, Pal U.

Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3788-E3797. doi: 10.1073/pnas.1718595115. Epub 2018 Apr 2.

4.

Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.

Cramer SD, Hixon JA, Andrews C, Porter RJ, Rodrigues GOL, Wu X, Back T, Czarra K, Michael H, Cam M, Chen J, Esposito D, Senkevitch E, Negi V, Aplan PD, Li W, Durum SK.

Leukemia. 2018 Aug;32(8):1795-1882. doi: 10.1038/s41375-017-0001-0. Epub 2018 Feb 15. No abstract available.

PMID:
29535426
5.

Autophagy RIPs into cell death.

Goodall ML, Cramer SD, Thorburn A.

Cell Cycle. 2016 Nov 16;15(22):3014-3015. Epub 2016 Aug 30. No abstract available.

6.

Autophagy complexes cell death by necroptosis.

Goodall ML, Cramer SD, Thorburn A.

Oncotarget. 2016 Aug 9;7(32):50818-50819. doi: 10.18632/oncotarget.10640. No abstract available.

7.

Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Cramer SD, Aplan PD, Durum SK.

Blood. 2016 Jul 28;128(4):473-8. doi: 10.1182/blood-2016-03-679209. Epub 2016 Jun 6. Review.

8.

The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.

Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD, Thorburn A.

Dev Cell. 2016 May 23;37(4):337-349. doi: 10.1016/j.devcel.2016.04.018.

9.

SPOP the mutation.

Rider L, Cramer SD.

Elife. 2015 Oct 27;4. pii: e11760. doi: 10.7554/eLife.11760.

10.

Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat.

Mandell E, Seedorf GJ, Ryan S, Gien J, Cramer SD, Abman SH.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 1;309(9):L1018-26. doi: 10.1152/ajplung.00253.2015. Epub 2015 Sep 4.

11.

Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.

Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, Lucia MS, Wu M, Shi L, Cimic A, Sirintrapun SJ, Nolley R, Pac C, Chen H, Peehl DM, Xu J, Liu W, Costello JC, Cramer SD.

Cancer Res. 2015 Mar 15;75(6):1021-34. doi: 10.1158/0008-5472.CAN-14-1596.

12.

Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.

Yu N, Puckett S, Antinozzi PA, Cramer SD, Lyles DS.

J Virol. 2015 May;89(10):5250-63. doi: 10.1128/JVI.00257-15. Epub 2015 Mar 4.

13.

Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.

Schlaepfer IR, Glodé LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH.

Mol Imaging Biol. 2015 Aug;17(4):529-38. doi: 10.1007/s11307-014-0814-4.

14.

Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.

Schlaepfer IR, Rider L, Rodrigues LU, Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM, Eckel RH, Cramer SD.

Mol Cancer Ther. 2014 Oct;13(10):2361-71. doi: 10.1158/1535-7163.MCT-14-0183. Epub 2014 Aug 13.

15.

Influence of stromal-epithelial interactions on androgen action.

Nieto CM, Rider LC, Cramer SD.

Endocr Relat Cancer. 2014 Aug;21(4):T147-60. doi: 10.1530/ERC-14-0138. Epub 2014 May 28. Review.

PMID:
24872510
16.

Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.

Ting HJ, Deep G, Jain AK, Cimic A, Sirintrapun J, Romero LM, Cramer SD, Agarwal C, Agarwal R.

Mol Carcinog. 2015 Sep;54(9):730-41. doi: 10.1002/mc.22135. Epub 2014 Feb 24.

17.

A role for interleukin-1 alpha in the 1,25 dihydroxyvitamin D3 response in mammary epithelial cells.

Maund SL, Shi L, Cramer SD.

PLoS One. 2013 Nov 7;8(11):e81367. doi: 10.1371/journal.pone.0081367. eCollection 2013.

18.

Genetic markers associated with early cancer-specific mortality following prostatectomy.

Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Grönberg H, Isaacs WB, Xu J.

Cancer. 2013 Jul 1;119(13):2405-12. doi: 10.1002/cncr.27954. Epub 2013 Apr 22.

19.

Suppression of Tak1 promotes prostate tumorigenesis.

Wu M, Shi L, Cimic A, Romero L, Sui G, Lees CJ, Cline JM, Seals DF, Sirintrapun JS, McCoy TP, Liu W, Kim JW, Hawkins GA, Peehl DM, Xu J, Cramer SD.

Cancer Res. 2012 Jun 1;72(11):2833-43. doi: 10.1158/0008-5472.CAN-11-2724. Epub 2012 Mar 30.

20.

Hydroxyproline metabolism in mouse models of primary hyperoxaluria.

Knight J, Holmes RP, Cramer SD, Takayama T, Salido E.

Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F688-93. doi: 10.1152/ajprenal.00473.2011. Epub 2011 Dec 21.

21.

Pathology in practice. Brain neoplasm.

Cramer SD, Campbell GA, Gray CW, Lamm CG.

J Am Vet Med Assoc. 2012 Jan 1;240(1):47-9. doi: 10.2460/javma.240.1.47. No abstract available.

PMID:
22171754
22.

Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.

Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, Chen YQ.

Carcinogenesis. 2012 Feb;33(2):404-12. doi: 10.1093/carcin/bgr290. Epub 2011 Dec 8.

23.

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.

Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T, Xie C, Wan M, Kim ST, Wang Z, Turner AR, Zhang Z, Feng J, Yan Y, Sun J, Bova GS, Ewing CM, Yan G, Gielzak M, Cramer SD, Vessella RL, Zheng SL, Grönberg H, Isaacs WB, Xu J.

Oncogene. 2012 Aug 30;31(35):3939-48. doi: 10.1038/onc.2011.554. Epub 2011 Dec 5.

24.

Clinical snapshot: Colitis in a paint gelding.

Cramer SD, Love B, Ritchey JW, Banse H.

Compend Contin Educ Vet. 2011 Dec;33(12):E4. No abstract available.

PMID:
23713155
25.

Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature.

Salmanzadeh A, Romero L, Shafiee H, Gallo-Villanueva RC, Stremler MA, Cramer SD, Davalos RV.

Lab Chip. 2012 Jan 7;12(1):182-9. doi: 10.1039/c1lc20701f. Epub 2011 Nov 9.

PMID:
22068834
26.

Pathology in practice. Liposarcoma.

Cramer SD, Porter KL, Rochat MC, Lamm CG.

J Am Vet Med Assoc. 2011 Sep 15;239(6):757-9. doi: 10.2460/javma.239.6.757. No abstract available.

PMID:
21916756
27.

Pseudorabies virus infection in Oklahoma hunting dogs.

Cramer SD, Campbell GA, Njaa BL, Morgan SE, Smith SK 2nd, McLin WR 4th, Brodersen BW, Wise AG, Scherba G, Langohr IM, Maes RK.

J Vet Diagn Invest. 2011 Sep;23(5):915-23. doi: 10.1177/1040638711416628. Erratum in: J Vet Diagn Invest. 2012 Jan;24(1):246.

PMID:
21908347
28.

Pathology in practice. Thymic lymphoma with vertebral bone marrow involvement, spinal cord compression, and Wallerian degeneration.

Cramer SD, Njaa BL, Genova SG, Gilliam JN.

J Am Vet Med Assoc. 2011 Jun 15;238(12):1565-7. doi: 10.2460/javma.238.12.1565. No abstract available.

PMID:
21671810
29.

Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.

Maund SL, Barclay WW, Hover LD, Axanova LS, Sui G, Hipp JD, Fleet JC, Thorburn A, Cramer SD.

Cancer Res. 2011 Aug 1;71(15):5276-86. doi: 10.1158/0008-5472.CAN-10-2160. Epub 2011 Jun 8.

30.

Sellar xanthogranuloma in a dog.

Cramer SD, Miller AD, Medici EL, Brunker JD, Ritchey JW.

J Vet Diagn Invest. 2011 Mar;23(2):387-90.

PMID:
21398471
31.

Pathology in practice. Squamous cell carcinoma of the penis with multifocal metastasis to the regional lymph nodes, lungs, and heart.

Cramer SD, Breshears MA, Qualls HJ.

J Am Vet Med Assoc. 2011 Mar 1;238(5):581-3. doi: 10.2460/javma.238.5.581. No abstract available.

PMID:
21355798
32.

Pancreatic cancer with Nest-in tendencies.

Maund SL, Cramer SD.

Cancer Biol Ther. 2011 Mar 15;11(6):559-61. Epub 2011 Mar 15. No abstract available.

33.

The tissue-specific stem cell as a target for chemoprevention.

Maund SL, Cramer SD.

Stem Cell Rev. 2011 Jun;7(2):307-14. doi: 10.1007/s12015-010-9205-7. Review.

34.

Regulation of Skp2 levels by the Pim-1 protein kinase.

Cen B, Mahajan S, Zemskova M, Beharry Z, Lin YW, Cramer SD, Lilly MB, Kraft AS.

J Biol Chem. 2010 Sep 17;285(38):29128-37. doi: 10.1074/jbc.M110.137240. Epub 2010 Jul 27.

35.

1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.

Axanova LS, Chen YQ, McCoy T, Sui G, Cramer SD.

Prostate. 2010 Nov 1;70(15):1658-71. doi: 10.1002/pros.21201.

36.

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.

Cao P, Deng Z, Wan M, Huang W, Cramer SD, Xu J, Lei M, Sui G.

Mol Cancer. 2010 May 17;9:108. doi: 10.1186/1476-4598-9-108.

37.

Yin Yang 1 regulates the transcriptional activity of androgen receptor.

Deng Z, Wan M, Cao P, Rao A, Cramer SD, Sui G.

Oncogene. 2009 Oct 22;28(42):3746-57. doi: 10.1038/onc.2009.231. Epub 2009 Aug 10.

38.

Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling.

Levin-Iaina N, Dinour D, Romero L, Ron R, Brady RL, Cramer SD, Holtzman EJ.

J Urol. 2009 May;181(5):2146-51. doi: 10.1016/j.juro.2009.01.045. Epub 2009 Mar 17.

PMID:
19296982
39.

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.

Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, Smith S, Pruett K, Romero LM, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Adolfsson J, Liu W, Kim JW, Duggan D, Carpten J, Zheng SL, Rodriguez C, Isaacs WB, Grönberg H, Xu J.

Hum Mol Genet. 2009 Apr 1;18(7):1368-75. doi: 10.1093/hmg/ddp035. Epub 2009 Jan 19.

40.

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.

Wiklund F, Zheng SL, Sun J, Adami HO, Lilja H, Hsu FC, Stattin P, Adolfsson J, Cramer SD, Duggan D, Carpten JD, Chang BL, Isaacs WB, Grönberg H, Xu J.

Prostate. 2009 Mar 1;69(4):419-27. doi: 10.1002/pros.20908.

41.

Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.

Cramer SD, Sun J, Zheng SL, Xu J, Peehl DM.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2451-7. doi: 10.1158/1055-9965.EPI-08-0374.

42.

Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation.

Barclay WW, Axanova LS, Chen W, Romero L, Maund SL, Soker S, Lees CJ, Cramer SD.

Stem Cells. 2008 Mar;26(3):600-10. Epub 2007 Nov 29.

43.

A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2.

Takayama T, Nagata M, Ozono S, Nonomura K, Cramer SD.

Nephrol Dial Transplant. 2007 Aug;22(8):2371-4. Epub 2007 May 17. No abstract available.

44.

Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.

Knight J, Holmes RP, Milliner DS, Monico CG, Cramer SD.

Nephrol Dial Transplant. 2006 Aug;21(8):2292-5. Epub 2006 Apr 5.

45.

5-Oxo-ETE analogs and the proliferation of cancer cells.

O'Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High K, Chen YQ, Willingham MC, Smitherman PK, Kute TE, Rao A, Cramer SD, Morrow CS.

Biochim Biophys Acta. 2005 Oct 1;1736(3):228-36. Epub 2005 Aug 30.

PMID:
16154383
46.

Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells.

Wansley EK, Dillon PJ, Gainey MD, Tam J, Cramer SD, Parks GD.

Virology. 2005 Apr 25;335(1):131-44.

47.

Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells.

Thorburn J, Moore F, Rao A, Barclay WW, Thomas LR, Grant KW, Cramer SD, Thorburn A.

Mol Biol Cell. 2005 Mar;16(3):1189-99. Epub 2005 Jan 5.

48.

Culture of mouse prostatic epithelial cells from genetically engineered mice.

Barclay WW, Cramer SD.

Prostate. 2005 May 15;63(3):291-8.

PMID:
15599944
49.
50.

Supplemental Content

Loading ...
Support Center